AcuMedic To Promote TCM In EU Market
This article was originally published in PharmAsia News
At a recent Sino-UK TCM modernization and industrialization seminar in Chongqing, UK-based Mei Group PLC disclosed that its subsidiary AcuMedic will promote the entry of TCM into the EU mainstream market by various means. With more western consumers accepting TCM, UK experts at the meeting said they will apply modern biotechnology to Chinese herbal research. At the same time, they will step up efforts to push for TCM standardization to meet EU requirements. The UK side hopes to leverage on Chongqing, the most important TCM base in South west China. By collaborating with the local TCM industry as well as R&D institutions in production and test technology, raw material purchase and talent training, the partners aim to jointly boost TCM internationalization. (Click here for more - Chinese Language)
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.